Document is current
Any future updates will be listed below
-
Authors
Piao, Yi https://orcid.org/0009-0008-3162-543X
Kimijima, Yuya https://orcid.org/0009-0004-4331-6598
,
Nakamura, Michihiko https://orcid.org/0009-0002-9980-4860
Matsui, Nobutomo https://orcid.org/0009-0008-7172-1426
-
Funding
Funding for this research was provided by:
PhRMA Japan
- License Information
-
More Information
Article History
Accepted: 5 June 2026
First Online: 24 June 2026
Declarations
:
: Not applicable.
: Yi Piao is an employee of Gilead Sciences. Yuya Kimijima is an employee of Bristol Myers Squibb. Michihiko Nakamura is an employee of IQVIA. Nobutomo Matsu is an employee of IQVIA.
: Both first authors, Yi Piao and Yuya Kimijima, contributed equally to conceptualization, resources, supervision, investigation, methodology, writing the original draft, project administration, editing, and final review. Michihiko Nakamura and Nobutomo Matsui contributed resources, writing the original draft, and final review. All authors read and approved the final version.
: The data used in this study consists of publicly available information and data obtained through interviews with EHR database vendors. Publicly available sources are cited within the manuscript. Information obtained through interviews is not publicly available, as it may include proprietary or confidential details provided by the respective organizations. No individual-level patient data was used in this study. Additional aggregated information supporting the findings of this study may be available from the corresponding author upon reasonable request, subject to applicable restrictions.
